Nitin Sood - Mar 4, 2022 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Commercial Officer
Signature
/s/ Nitin Sood by Eric Billings, attorney-in-fact
Stock symbol
ADPT
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 08:01 PM
Previous filing
Aug 18, 2021
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +65.9K +67.79% $0.00 163K Mar 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Award $0 +165K $0.00 165K Mar 4, 2022 Common Stock 165K $12.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.